Atlas Trials

Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel

Clinical trial NCT04561089 · COMPLETED

Trial details

NCT number
NCT04561089
Sponsor
Illumina, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
SARS-CoV-2
Start date
2020-02-13
Primary completion
2021-02-28
Enrollment
763

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.